Many of the most devastating infectious diseases are caused by RNA viruses, and Model Medicines is working on one compound to ...

Merit Financial Group LLC grew its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 60.8% during the fourth quarter, ...

Ritholtz Wealth Management decreased its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 39.4% during the 4th ...

Pfizer divests $3.05 billion of Haleon shares, cutting its stake to 7.3% in a strategic shift to refocus on core ...

At the JPM conference, Pfizer CEO Albert Bourla projected optimism, saying the market was overlooking the pharma company's ...

A report on the experiences of 13 patients found that the drug had no benefit for some and that some who benefited said the ...

aClinical Epidemiology Center, Research and Development Service, VA Saint Louis Health Care System, Saint Louis, MO, USA bVeterans Research and Education Foundation of Saint Louis, Saint Louis, MO, ...

Also Read: Pfizer's Paxlovid Demonstrates Safety But ... that traditional medical records may overlook. Extended antiviral courses have precedent in other conditions like HIV and hepatitis C ...

Also Read: Pfizer's Paxlovid Demonstrates Safety But Raises Questions ... sheds light on lived experiences that traditional medical records may overlook. Extended antiviral courses have precedent in ...